Literature DB >> 8920216

Feline fibrosarcomas at vaccination sites and non-vaccination sites.

F D Doddy1, L T Glickman, N W Glickman, E B Janovitz.   

Abstract

A retrospective study of 195 feline sarcomas diagnosed histologically between July 1988 and June 1994 showed that 170 (87.2%) were fibrosarcomas. Cats with vaccination site (VS) fibrosarcomas were younger (8.6 +/- 3.9 years; median = 8 years) than cats with non-vaccination site (NVS) fibrosarcomas (10.2 +/- 4.7 years; median = 11 years) (P = 0.03), but there was no such association with breed, sex, or "neuter status". Microscopical features more characteristic of VS fibrosarcomas than of NVS fibrosarcomas were (1) subcutaneous location (P < 0.001), (2) necrosis (P < 0.001), (3) inflammatory cell infiltration (P < 0.001), (4) increased mitotic activity (P < 0.02), (5) pleomorphism (P < 0.001), and (6) variability in the density of the extracellular matrix (P < 0.001). When these data were fitted to a logistic regression model, younger age (P = 0.003), subcutaneous location of the fibrosarcoma (P = 0.0002), and the presence of inflammation (P = 0.017) were more characteristic of VS fibrosarcomas than of NVS fibrosarcomas. The study showed that in the absence of any vaccination history, the age of a cat, coupled with certain histological characteristics (e.g., tumour location in skin, and inflammation), may help in distinguishing VS fibrosarcomas from NVS fibrosarcomas. The characteristic histological features of VS fibrosarcomas, such as necrosis, increased mitotic activity and pleomorphism, are those of aggressive tumours.

Entities:  

Mesh:

Year:  1996        PMID: 8920216     DOI: 10.1016/s0021-9975(96)80005-3

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  13 in total

1.  Investigating the role of signal transducer and activator of transcription 3 in feline injection site sarcoma.

Authors:  Cheng-Hsin Shih; Yen-Chen Chang; Yun-Chiang Lai; Hue-Ying Chiou
Journal:  BMC Vet Res       Date:  2022-07-14       Impact factor: 2.792

2.  Temporal changes in characteristics of injection-site sarcomas in cats: 392 cases (1990-2006).

Authors:  Stephen C Shaw; Michael S Kent; Ira K Gordon; Cameron J Collins; Tamara A Greasby; Laurel A Beckett; Genevieve M Hammond; Katherine A Skorupski
Journal:  J Am Vet Med Assoc       Date:  2009-02-01       Impact factor: 1.936

3.  Microarray-based cytogenetic profiling reveals recurrent and subtype-associated genomic copy number aberrations in feline sarcomas.

Authors:  Rachael Thomas; Victor E Valli; Peter Ellis; Jerold Bell; Elinor K Karlsson; John Cullen; Kerstin Lindblad-Toh; Cordelia F Langford; Matthew Breen
Journal:  Chromosome Res       Date:  2009-11-26       Impact factor: 5.239

4.  Targeting a newly established spontaneous feline fibrosarcoma cell line by gene transfer.

Authors:  Rounak Nande; Altomare Di Benedetto; Pierpaolo Aimola; Flavia De Carlo; Miranda Carper; Charlene D Claudio; Jim Denvir; Jagan Valluri; Gary C Duncan; Pier Paolo Claudio
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

Review 5.  Cats, Cancer and Comparative Oncology.

Authors:  Claire M Cannon
Journal:  Vet Sci       Date:  2015-06-30

6.  Hepatic fibrosarcoma incarcerated in a peritoneopericardial diaphragmatic hernia in a cat.

Authors:  Michael Linton; Lydia Tong; Adrian Simon; Eugene Buffa; Ross McGregor; Julien Labruyére; Darren Foster
Journal:  JFMS Open Rep       Date:  2016-03-17

7.  Distribution of Glutathione-Stabilized Gold Nanoparticles in Feline Fibrosarcomas and Their Role as a Drug Delivery System for Doxorubicin-Preclinical Studies in a Murine Model.

Authors:  Katarzyna Zabielska-Koczywąs; Anna Wojtalewicz; Ewelina Użarowska; Agata Klejman; Agata Wojtkowska; Izabella Dolka; Marek Wojnicki; Katarzyna Sobczak; Michał Wójcik; Haifa Shen; Mauro Ferrari; Roman Lechowski
Journal:  Int J Mol Sci       Date:  2018-03-29       Impact factor: 5.923

Review 8.  Vaccine-associated feline sarcoma: current perspectives.

Authors:  Corey F Saba
Journal:  Vet Med (Auckl)       Date:  2017-01-12

9.  Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review.

Authors:  Kevin N Woodward
Journal:  ISRN Vet Sci       Date:  2011-04-12

10.  Mechanism of immunopotentiation and safety of aluminum adjuvants.

Authors:  Harm Hogenesch
Journal:  Front Immunol       Date:  2013-01-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.